Literature DB >> 29388463

Endogenous markers for kidney function in children: a review.

Emil den Bakker1, Reinoud J B J Gemke1, Arend Bökenkamp1.   

Abstract

Although glomerular filtration rate (GFR) in children can be measured using a gold-standard technique following injection of an exogenous marker, this invasive and cumbersome technique is not widely available and GFR is commonly estimated using serum levels of endogenous markers. Creatinine, urea, cystatin C, beta-trace protein, and beta-2 microglobulin are well-established endogenous markers of kidney function. These markers differ in site of production and effects of diet and medication, as well as renal-tubular handling and extra-renal elimination. For each marker, different methods are available for measurement. Importantly, the measurements of creatinine and cystatin C have recently been standardized with the introduction of international reference standards. In order to allow estimation of GFR from serum marker concentrations, different equations for estimated GFR (eGFR) have been developed in children, using simple or more complex regression strategies with gold standard GFR measurements as a dependent variable. As a rule, estimation strategies relying on more than one marker - either by calculating the average of single parameter equations or by using more complex equations incorporating several parameters - outperform eGFR estimations using only a single marker. This in-depth review will discuss the physiology, measurement and clinical use of creatinine, urea, cystatin C, beta-trace protein, and beta-2 microglobulin in children. It will also address the generation of eGFR equations in children and provide an overview of currently available eGFR equations for the pediatric age group.

Entities:  

Keywords:  Cystatin C; beta-2 microglobulin; beta-trace protein; clearance study; creatinine; estimated GFR; physiology; urea

Mesh:

Substances:

Year:  2018        PMID: 29388463     DOI: 10.1080/10408363.2018.1427041

Source DB:  PubMed          Journal:  Crit Rev Clin Lab Sci        ISSN: 1040-8363            Impact factor:   6.250


  14 in total

1.  Validation of standardized creatinine and cystatin C GFR estimating equations in a large multicentre European cohort of children.

Authors:  Jonas Björk; Ulf Nyman; Ulla Berg; Pierre Delanaye; Laurence Dubourg; Karolien Goffin; Anders Grubb; Magnus Hansson; Karin Littmann; Kajsa Åsling-Monemi; Arend Bökenkamp; Hans Pottel
Journal:  Pediatr Nephrol       Date:  2019-02-04       Impact factor: 3.714

2.  The role of urinary NGAL and serum cystatin C in assessing the severity of ureteropelvic junction obstruction in infants.

Authors:  Antigoni Pavlaki; Nikoleta Printza; Evangelia Farmaki; Stella Stabouli; Anna Taparkou; Magdalini Sterpi; John Dotis; Fotios Papachristou
Journal:  Pediatr Nephrol       Date:  2019-10-13       Impact factor: 3.714

3.  Impact of Metabolic Acidosis and Alkali Therapy on Linear Growth in Children with Chronic Kidney Disease: What Is the Current Evidence?

Authors:  Emma H Ulrich; Rahul Chanchlani
Journal:  Kidney360       Date:  2022-03-09

4.  Combining GFR estimates from cystatin C and creatinine-what is the optimal mix?

Authors:  Emil den Bakker; Reinoud Gemke; Joanna A E van Wijk; Isabelle Hubeek; Birgit Stoffel-Wagner; Arend Bökenkamp
Journal:  Pediatr Nephrol       Date:  2018-05-17       Impact factor: 3.714

Review 5.  CKD: A Call for an Age-Adapted Definition.

Authors:  Pierre Delanaye; Kitty J Jager; Arend Bökenkamp; Anders Christensson; Laurence Dubourg; Bjørn Odvar Eriksen; François Gaillard; Giovanni Gambaro; Markus van der Giet; Richard J Glassock; Olafur S Indridason; Marco van Londen; Christophe Mariat; Toralf Melsom; Olivier Moranne; Gunnar Nordin; Runolfur Palsson; Hans Pottel; Andrew D Rule; Elke Schaeffner; Maarten W Taal; Christine White; Anders Grubb; Jan A J G van den Brand
Journal:  J Am Soc Nephrol       Date:  2019-09-10       Impact factor: 10.121

6.  Augmented renal clearance in pediatric intensive care: are we undertreating our sickest patients?

Authors:  Evelyn Dhont; Tatjana Van Der Heggen; Annick De Jaeger; Johan Vande Walle; Peter De Paepe; Pieter A De Cock
Journal:  Pediatr Nephrol       Date:  2018-10-29       Impact factor: 3.714

7.  Carboplatin Dosing in Children Using Estimated Glomerular Filtration Rate: Equation Matters.

Authors:  Mirjam E van de Velde; Emil den Bakker; Hester N Blufpand; Gertjan L Kaspers; Floor C H Abbink; Arjenne W A Kors; Abraham J Wilhelm; Richard J Honeywell; Godefridus J Peters; Birgit Stoffel-Wagner; Laurien M Buffart; Arend Bökenkamp
Journal:  Cancers (Basel)       Date:  2021-11-26       Impact factor: 6.639

8.  Late effects of high-dose methotrexate treatment in childhood cancer survivors-a systematic review.

Authors:  Maria Otth; Katrin Scheinemann; Eveline Daetwyler; Mario Bargetzi
Journal:  BMC Cancer       Date:  2022-03-14       Impact factor: 4.430

Review 9.  Assessment of kidney function: clinical indications for measured GFR.

Authors:  Natalie Ebert; Sebastjan Bevc; Arend Bökenkamp; Francois Gaillard; Mads Hornum; Kitty J Jager; Christophe Mariat; Bjørn Odvar Eriksen; Runolfur Palsson; Andrew D Rule; Marco van Londen; Christine White; Elke Schaeffner
Journal:  Clin Kidney J       Date:  2021-02-22

Review 10.  Managing the combined consequences of COVID-19 infection and lock-down policies on athletes: narrative review and guidelines proposal for a safe return to sport.

Authors:  Jean-Bernard Fabre; Laurent Grelot; William Vanbiervielt; Julien Mazerie; Raphael Manca; Vincent Martin
Journal:  BMJ Open Sport Exerc Med       Date:  2020-10-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.